Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday

Benzinga04-17

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Wall Street expects Abbott Laboratories (NYSE:ABT) to report quarterly earnings at 95 cents per share on revenue of $9.88 billion before the opening bell, according to data from Benzinga Pro. Abbott shares gained 1% to $110.30 in after-hours trading.

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) disclosed a $500 million proposed public offering of common stock. Intra-Cellular Therapies shares fell 1.3% to $78.80 in the after-hours trading session.

Analysts are expecting U.S. Bancorp (NYSE:USB) to post quarterly earnings at 88 cents per share on revenue of $6.72 billion. The company will release earnings before the markets open. U.S. Bancorp shares fell 0.6% to $40.75 in after-hours trading.

Check out our premarket coverage here

Ontrak, Inc. (NASDAQ:OTRK) reported worse-than-expected fourth-quarter financial results. The company posted adjusted loss of 27 cents per share, compared to market expectations for a loss of 21 cents per share. The company's quarterly sales came in at $3.539 million, missing estimates of $4.037 million. Ontrak shares fell 14.2% to $0.3949 in the after-hours trading session.

Analysts expect The Travelers Companies, Inc. (NYSE:TRV) to post quarterly earnings at $4.90 per share on revenue of $10.51 billion before the opening bell. Travelers shares gained 0.8% to $224.98 in after-hours trading.

Check This Out: Top 4 Tech Stocks You May Want To Dump In April

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment